Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT
Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT
The purpose of this study is to evaluate the safety and efficacy of Melphalan and BUCY+VP-16
 myeloablative conditioning regimens in multiple myeloma undergoing autologous hematopoietic
 stem cell transplantation.
Inclusion Criteria:

 -  Multiple Myeloma patients

 -  Achieving at least VGPR after chemotherapy, then mobilizing and collecting of
 peripheral blood stem cells

 Exclusion Criteria:

 -  Any abnormality in a vital sign (e.g., heart rate, respiratory rate, or blood
 pressure)

 -  Patients with any conditions not suitable for the trial (investigators' decision